125,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 6-10 Tagen
payback
63 °P sammeln
  • Gebundenes Buch

Integrative Pancreatic Intervention Therapy: A Holistic Approach summarizes, in a systematic manner, the diagnosis and treatment of late, critical pancreatic diseases. The book gives insights into each interventional technique, with an ultimate goal of improving survival rates for late stage pancreatic cancer patients. Six sections cover basic and transformation research on pancreatic diseases, interventional therapy for benign pancreatic disease, interventional therapy for malignant pancreatic diseases, interventional therapy for pancreative cancer-related lesions, stem cell and targeted…mehr

Produktbeschreibung
Integrative Pancreatic Intervention Therapy: A Holistic Approach summarizes, in a systematic manner, the diagnosis and treatment of late, critical pancreatic diseases. The book gives insights into each interventional technique, with an ultimate goal of improving survival rates for late stage pancreatic cancer patients. Six sections cover basic and transformation research on pancreatic diseases, interventional therapy for benign pancreatic disease, interventional therapy for malignant pancreatic diseases, interventional therapy for pancreative cancer-related lesions, stem cell and targeted molecular therapy for pancreative carcinoma, and combined interventional therapy for pancreative carcinoma.

This book will be useful for those looking to understand how best to apply interventional therapy for the improvement of late state pancreatic cancer treatment.
Autorenporträt
Maoquan Li is Professor in the Department of Interventional and Vascular Therapy at Shanghai Tenth People's Hospital at Tongji University. He specializes in interventional radiology. He was the first interventional radiologist in China to conduct interventional treatment of gastric cancer, adrenal tumors, embolization of uterine fibroids, rheological thrombolytic therapy, interventional comprehensive therapy for diabetic vascular disease, interventional comprehensive treatment for chronic thrombus, and the molecular targeted therapy of aesthetic liver cancer. He is a leader in the field.